CHILLA', ANASTASIA
 Distribuzione geografica
Continente #
NA - Nord America 1.979
EU - Europa 1.929
AS - Asia 291
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 4.204
Nazione #
US - Stati Uniti d'America 1.975
PL - Polonia 1.114
IT - Italia 253
IE - Irlanda 189
SE - Svezia 188
HK - Hong Kong 96
JO - Giordania 72
CN - Cina 69
GB - Regno Unito 44
VN - Vietnam 28
FI - Finlandia 24
BE - Belgio 23
DE - Germania 23
RU - Federazione Russa 20
CH - Svizzera 14
SG - Singapore 12
AT - Austria 11
FR - Francia 10
ES - Italia 8
IN - India 8
TR - Turchia 6
UA - Ucraina 6
CA - Canada 3
NL - Olanda 2
TN - Tunisia 2
AU - Australia 1
CL - Cile 1
CR - Costa Rica 1
MU - Mauritius 1
Totale 4.204
Città #
Warsaw 1.114
Fairfield 312
Chandler 245
Dublin 189
Ashburn 168
Ann Arbor 149
Woodbridge 139
Seattle 125
Houston 120
Cambridge 113
Florence 94
Wilmington 94
Hong Kong 64
Altamura 59
Lawrence 58
Princeton 46
Beijing 36
Buffalo 28
Boston 25
Brussels 23
Boardman 22
Medford 21
Moscow 20
Shanghai 20
Dong Ket 18
San Diego 18
Bern 14
Vienna 11
Jacksonville 10
Singapore 10
Norwalk 9
Barcelona 8
New York 8
Hillsboro 7
Phoenix 7
Zhengzhou 7
Izmir 6
Pune 6
Bari 5
Fiesole 5
Redmond 5
Bremen 4
London 4
Milan 4
Prato 4
West Jordan 4
Chiusi 3
Grafing 3
Hangzhou 3
Palaiseau 3
Poggio a Caiano 3
Rome 3
Toronto 3
Bientina 2
Bologna 2
Falls Church 2
Formigine 2
Frankfurt Am Main 2
Pian di Scò 2
Santa Clara 2
Tappahannock 2
Tunis 2
Acton 1
Amsterdam 1
Andover 1
Avellino 1
Bagno A Ripoli 1
Birmingham 1
Brescia 1
Castelliri 1
Catania 1
Cedar Knolls 1
Changchun 1
Chiswick 1
Fabriano 1
Grevenbroich 1
Groningen 1
L'aquila 1
Laurel 1
Leawood 1
Los Angeles 1
Messina 1
Miami Beach 1
Migliarino Pisano 1
Misano Adriatico 1
Montigny-le-bretonneux 1
Nanjing 1
Napoli 1
New Bedfont 1
Nürnberg 1
Paris 1
Pinerolo 1
Pisa 1
Poggiomarino 1
Prescot 1
Salerno 1
San Jose 1
San José 1
Scandicci 1
Simi Valley 1
Totale 3.535
Nome #
Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis 254
Chronic resveratrol treatment inhibits MRC5 fibroblast SASP-related pro-tumoral effects on melanoma cells 247
GDF5 regulates TGFß-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGFß peptides 243
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells 224
u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression 218
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 206
Type II CRISPR/Cas9 approach in the oncological therapy 205
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 172
Correction: Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: Deregulation in Systemic sclerosis (PLoS ONE (2013) 8, 7, (e68117) doi: 10.1371/journal.pone.0068117) 151
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme 136
Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A "cellular stove" approach to the photoablation of melanoma 127
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 122
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: The amoeboid angiogenesis 119
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis. 118
Endothelial Progenitor Cells as Shuttle of Anticancer Agents 116
Urokinase and its receptor in follicular and inflammatory cysts of the jaws. 115
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells 111
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. 106
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8 96
Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. 90
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. 87
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 82
Proteomic identification of VEGF-dependent protein enrichment to membrane caveolar-raft microdomains in endothelial progenitor cells. 81
Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. 75
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. 69
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 68
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 68
Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a CTGF(CCN2)/TGF-beta-dependent mesechymal-to mesenchymal transition 64
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 58
Anti-urokinase receptor antisense oligonucleotide (uPar-aODN) to prevent and cure long-term space exploration related retinal pathological angiogenesis 53
Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by Anti-TGF-β Peptides 49
Plasticity in Endothelial Cells and Endothelial Progenitor Cells: uPAR-mediated Amoeboid Angiogenesis 46
Delivery systems of CRISPR/Cas9-based cancer gene therapy 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 45
Chronic treatment with resveratrol and olive oil phenols on MRC5 fibroblast SASP: inhibition of pro-tumoral microenvironment 38
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 37
A Possible Role for PAI-1 Blockade in Melanoma Immunotherapy 35
Th17 lymphocyte-dependent degradation of joint cartilage by synovial fibroblasts in a humanized mouse model of arthritis and reversal by secukinumab 32
Cell-mediated release of nanoparticles as a preferential option for future treatment of melanoma 30
Olive phenols preserve lamin B1 expression reducing cGAS/STING/NFκB-mediated SASP in ionizing radiation-induced senescence. 28
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 26
Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling 23
Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent-Associated Secretory Phenotype" on endothelial colony-forming cells: The role of IL8 22
Water diffusion effects at gold-graphene interfaces supporting surface plasmon polaritons 21
Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways 4
Tipifarnib as a precision therapy for HRAS-mutant head and neck squamous cell carcinomas 3
PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis 2
Effects of cilengitide in osteoclast maturation and behavior 2
Pulsed-Laser-Driven CO2 Reduction Reaction for the Control of the Photoluminescence Quantum Yield of Organometallic Gold Nanocomposites 1
Totale 4.325
Categoria #
all - tutte 11.263
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.263


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019239 0 0 0 0 0 0 0 0 0 0 135 104
2019/2020861 64 71 21 65 100 80 79 116 85 72 95 13
2020/2021749 47 98 20 94 49 57 50 53 63 140 38 40
2021/2022343 16 28 25 20 17 11 16 29 18 17 61 85
2022/20231.012 83 221 38 85 73 155 113 70 121 6 25 22
2023/2024370 7 38 46 12 23 81 22 91 6 44 0 0
Totale 4.325